Company / Interest Expense
ARS Pharmaceuticals, Inc. Interest Expense History
FY2020-FY2021 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Interest Expense
$106.0K
FY2021
5-year range
$106.0K / $106.0K
FY2020-FY2021
Trend
+465.5%
vs FY2020
Sector context
#38 of 44
Health Care
What the data says
ARS Pharmaceuticals, Inc.'s interest expense of $106,000 is lower than 86% of companies in the Health Care sector (FY2021).
Based on SEC 10-K filings.
$106,000 in FY2021.
Health Care sector context is included.
Interest Expense over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Top 14% in Health CareTop 14% of 44This company $106.0K Sector average $291.0M
▼
-100.0% below sector average
Key checks
Key Insights
- In FY2021, interest expense increased 465.5% year-over-year.
- Ranks #38 out of 44 companies in the Health Care sector.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -1.44 (distress zone, below 1.8 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Interest ExpenseValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | - | - |
| FY2024 | - | - |
| FY2023 | - | - |
| FY2022 | - | - |
| FY2021 | $106.0K | +465.5% |
| FY2020 | -$29.0K | - |
As of FY2021 · SEC 10-K · Updated Jun 30, 2026